{"date":"2025-12-18","count":28,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4129-2025-12-18-2024-aqf99d","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"20:24:46","subject":"公告董事會決議增加對澳洲子公司增資案","clause":"第15款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2025-12-18 20:24，「公告董事會決議增加對澳洲子公司增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2025-12-18-2024-1d0cpzz","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"20:24:10","subject":"依公開發行公司資金貸與及背書保證處理準則第二十五條第四款公告","clause":"第22款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2025-12-18 20:24，「依公開發行公司資金貸與及背書保證處理準則第二十五條第四款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2025-12-18-2022-10lqs79","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"20:22:44","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第三款公告","clause":"第23款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2025-12-18 20:22，「依公開發行公司資金貸與及背書保證處理準則第二十二條第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2025-12-18-2021-10lqs79","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"20:21:33","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第三款公告","clause":"第23款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2025-12-18 20:21，「依公開發行公司資金貸與及背書保證處理準則第二十二條第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2025-12-18-2018-isqttc","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"20:18:51","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2025-12-18 20:18，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-12-18-2006-xo2pc7","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-12-18","time":"20:06:27","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第11款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-12-18 20:06，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2025-12-18-1803-1njncgj","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"18:03:26","subject":"公告本公司最近一年累積取得有價證券達公告標準","clause":"第20款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2025-12-18 18:03，「公告本公司最近一年累積取得有價證券達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-12-18-1754-79lrbq","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"17:54:14","subject":"補充說明113/11/20本公司收到智慧財產及商業法院商業庭來函，有關投保中心請求解任董事職務之宣判結果","clause":"第2款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-12-18 17:54，「補充說明113/11/20本公司收到智慧財產及商業法院商業庭來函，有關投保中心請求解任董事職務之宣判結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-12-18-1751-1muo30n","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"17:51:45","subject":"公告本公司辦理股票初次上櫃過額配售內容","clause":"第44款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-12-18 17:51，「公告本公司辦理股票初次上櫃過額配售內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-12-18-1750-ahexl4","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"17:50:55","subject":"公告本公司股票初次上櫃前現金增資員工認購股款催繳事宜","clause":"第44款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-12-18 17:50，「公告本公司股票初次上櫃前現金增資員工認購股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2025-12-18-1641-1i813pn","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2025-12-18","time":"16:41:21","subject":"公告本公司114年12月18日董事會重要決議事項","clause":"第44款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2025-12-18 16:41，「公告本公司114年12月18日董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2025-12-18-1634-1oxnj6n","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-12-18","time":"16:34:31","subject":"董事會決議114年度第3季不發放股利","clause":"第31款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-12-18 16:34，「董事會決議114年度第3季不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-12-18-1634-19b1djy","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"16:34:00","subject":"公告本公司配合會計師事務所內部輪調變更會計師","clause":"第7款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-12-18 16:34，「公告本公司配合會計師事務所內部輪調變更會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2025-12-18-1622-1tc5p6d","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2025-12-18","time":"16:22:40","subject":"公告本公司受邀參加康和綜合證券舉辦之興櫃前法人說明會。","clause":"第9款","fact_date":"2025-12-19","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2025-12-18 16:22，「公告本公司受邀參加康和綜合證券舉辦之興櫃前法人說明會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2025-12-18-1614-1lbkl7y","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2025-12-18","time":"16:14:14","subject":"代重要子公司江蘇松德生物科技有限公司公告董事會決議不分派113年度股利","clause":"第31款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2025-12-18 16:14，「代重要子公司江蘇松德生物科技有限公司公告董事會決議不分派113年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2025-12-18-1612-wr0tu2","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2025-12-18","time":"16:12:43","subject":"公告本公司總經理異動","clause":"第6款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2025-12-18 16:12，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2025-12-18-1600-t0qg86","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2025-12-18","time":"16:00:42","subject":"本公司新藥AD17002治療中度至重度嗜酸性白血球型氣喘臨床二期試驗案收受首位受試者","clause":"第44款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2025-12-18 16:00，「本公司新藥AD17002治療中度至重度嗜酸性白血球型氣喘臨床二期試驗案收受首位受試者」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-12-18-1557-1xqdn61","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-12-18","time":"15:57:19","subject":"代本公司重要子公司葡眾企業(股)公司公告董事會決議向關係人葡萄王生技(股)公司承租高雄營運中心到期續約","clause":"第20款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-12-18 15:57，「代本公司重要子公司葡眾企業(股)公司公告董事會決議向關係人葡萄王生技(股)公司承租高雄營運中心到期續約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-12-18-1543-1qlxm1","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-12-18","time":"15:43:18","subject":"公告本公司受邀參加華南永昌綜合證券股份有限公司舉辦之法人說明會","clause":"第12款","fact_date":"2025-12-19","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-12-18 15:43，「公告本公司受邀參加華南永昌綜合證券股份有限公司舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-12-18-1542-1egfkms","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-12-18","time":"15:42:33","subject":"公告本公司董事會通過重要決議","clause":"第51款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-12-18 15:42，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-12-18-1511-1gjsi9h","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-12-18","time":"15:11:34","subject":"公告本公司國內第二次無擔保轉換公司債收足債款","clause":"第51款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-12-18 15:11，「公告本公司國內第二次無擔保轉換公司債收足債款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-12-18-1507-xo2pc7","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-12-18","time":"15:07:01","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第9款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-12-18 15:07，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2025-12-18-1427-1qehggy","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"14:27:50","subject":"公告本公司受邀參加華南永昌綜合證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-22","cite_as":"公開資訊觀測站重大訊息：合世（1781），2025-12-18 14:27，「公告本公司受邀參加華南永昌綜合證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-12-18-1417-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-12-18","time":"14:17:59","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"第14款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-12-18 14:17，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-12-18-1417-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-12-18","time":"14:17:29","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"第14款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-12-18 14:17，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-12-18-1332-q1wnzv","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"13:32:39","subject":"公告本公司董事會通過總經理異動案","clause":"第6款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-12-18 13:32，「公告本公司董事會通過總經理異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-12-18-1320-1su03io","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-12-18","time":"13:20:04","subject":"公告本公司執行長異動","clause":"第8款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-12-18 13:20，「公告本公司執行長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2025-12-18-1303-m9oa22","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2025-12-18","time":"13:03:17","subject":"公告本公司訂定114年現金增資認股基準日等相關事宜","clause":"第11款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2025-12-18 13:03，「公告本公司訂定114年現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}